Laurus Labs Limited (NSE:LAURUSLABS)
1,166.40
+65.45 (5.94%)
May 4, 2026, 3:29 PM IST
Laurus Labs Revenue
In the fiscal year ending March 31, 2026, Laurus Labs had annual revenue of 68.68B INR with 23.66% growth. Laurus Labs had revenue of 18.23B in the quarter ending March 31, 2026, with 5.99% growth.
Revenue
68.68B
Revenue Growth
+23.66%
P/S Ratio
8.65
Revenue / Employee
11.14M
Employees
6,167
Market Cap
594.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 68.68B | 13.14B | 23.66% |
| Mar 31, 2025 | 55.54B | 5.13B | 10.18% |
| Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
| Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
| Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Mankind Pharma | 139.14B |
| Ipca Laboratories | 95.06B |
| Emcure Pharmaceuticals | 88.50B |
Laurus Labs News
- 3 days ago - Laurus Labs Ltd (BOM:540222) Q4 2026 Earnings Call Highlights: Robust Revenue Growth and ... - GuruFocus
- 3 days ago - Q4 2026 Laurus Labs Ltd Earnings Call Transcript - GuruFocus
- 4 days ago - Laurus Labs Transcript: Q4 25/26 - Transcripts
- 4 days ago - Laurus Labs announces voluntary closure of Laurus Generics GmbH - Business Upturn
- 4 days ago - Laurus Labs approves €9.8 million investment in KRKA Pharma joint venture - Business Upturn
- 4 days ago - Laurus Labs reports ₹6,813 crore revenue for FY26 with 23% growth - Business Upturn
- 4 days ago - Laurus Labs Q4 Results: Profit rises 19% YoY as margin expands nearly 400 bps - Business Upturn
- 4 days ago - Laurus Labs to invest ₹82 crore in joint venture and appoints two new independent directors - Business Upturn